TCT 2009 schedule
Here is the page we will use to coordinate the TV events at TCT 2009. The filming will take place in Room East 264 at the Moscone Convention Center.
Click on Date for Detailed Schedule
Tuesday September 22, 2009
12:30 PM
12:30 PM - 1:00 PM
- Interviewee: Peter Smits
- Trial: COMPARE. A Prospective, Randomized Trial of Everolimus-eluting vs. Paclitaxel-Eluting Stents
- Phone number:
1:00 PM
1:00 PM - 1:30 PM
- Interviewee: Shamir Mehta
- Trial: CURRENT-PCI OASIS 7. A Prospective, Randomized, Placebo-Controlled Trial of High- vs. Standard-Dose Clopidogrel and High- vs. Low-Dose Aspirin in Patients Undergoing PCI for ACS
- Phone number:
2:00 PM
2:00 PM - 2:30 PM
- Interviewee: John Spertus
- Trial: NEVO RES-ELUTION I QOL: Formal Quality-of-Life Assessment from a Prospective Trial of a Novel Sirolimus-Eluting Stent and a Paclitaxel-Eluting Stent
- Phone number:
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Eberhard Grube
- Trial: BIOFREEDOM: A Prospective Randomized Trial of a Polymer-Free Biolimus A9-Eluting Stent
- Phone number:
3:00 PM
3:00 PM - 3:30 PM
- Interviewee: David Allie
- Trial: CROSS-CLI: A Prospective Multicenter Registry of Ultrasound-Facilitated Recanalization of Peripheral Chronic Total Occlusions
- Phone number:
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Douglas Losordo
- Trial: ACT34-CMI: One-Year Results from a Prospective, Randomized, Placebo-Controlled Phase II Trial of CD34+ Cells in Patients with Refractory Angina
- Phone number:
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Gary Ansel
- Trial: ARMOUR: A Prospective, Nonrandomized Study of the Mo.Ma Proximal Cerebral Protection Device in High Surgical Risk Subjects Undergoing Carotid Artery Stenting
- Phone number:
4:30 PM
4:30 PM - 5:00 PM
- Interviewee: Ran Kornowski
- Trial:
- Phone number:
5:00 PM
5:00 PM - 5:30 PM
- Interviewee: Francesco Prati
- Trial: COCKTAIL: A Prospective Randomized Trial of Intracoronary Abciximab Infusion in Patients with Thrombotic Lesions Assessed by OCT
- Phone number:
Wednesday September 23, 2009
8:30 AM
8:30 AM - 9:00 AM
- Interviewee: William Fearon
- Trial: FAME: 2-Year Follow-up From a Prospective, Randomized Trial of FFR-Guided vs. Angiography-Guided PCI in Patients with Multivessel Coronary Artery Disease
- Phone number:
9:00 AM
9:00 AM - 9:30 AM
- Interviewee: Lorenz Raber
- Trial: SIRTAX-LATE. 5-Year Clinical and Angiographic Follow-up from a Prospective, Randomized Trial of Sirolimus-Eluting and Paclitaxel-Eluting Stents
- Phone number:
9:30 AM
9:30 AM - 10:00 AM
- Interviewee: Volker Klauss
- Trial: LEADERS. 2-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-Eluting Stents with a Bioabsorbable Polymer vs. Sirolimus-Eluting Stents with a Durable Polymer
- Phone number:
10:00 AM
10:00 AM - 10:30 AM
- Interviewee: Deepak Bhatt
- Trial: 1) COGENT. A Prospective, Randomized, Placebo-Controlled Trial of Omeprazole in Patients Receiving Aspirin and Clopidogrel
2) CHARISMA GENOMICS SUBSTUDY. Evaluation of the CYP2C19 Polymorphism in a Prospective, Randomized, Placebo-Controlled Trial of Chronic Clopidogrel Use for Primary and Secondary Prevention
- Phone number:
10:30 AM
10:30 AM - 11:00 AM
- Interviewee: David Cohen
- Trial: TRITON-TIMI 38 ECONOMIC SUBSTUDY. Cost-Effectiveness of Prasugrel vs. Clopidogrel From a Prospective, Randomized Trial of Patients with ACS Undergoing PCI
- Phone number:
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Chris Cannon
- Trial: PLATO INVASIVE. A Prospective, Randomized, Placebo-Controlled Trial of Ticagrelor vs. Clopidogrel in Patients with ACS Managed with an Invasive Strategy
- Phone number:
12:00 PM
12:00 PM - 12:30 PM
- Interviewee: Robert Byrne
- Trial: ISAR-DESIRE 2. A Prospective, Randomized Trial of Paclitaxel-Eluting vs. Sirolimus-Eluting Stents for Treatment of Restenosis in Sirolimus-Eluting Stents
- Phone number:
Thursday September 24, 2009
12:45 PM
12:45 PM - 1:15 PM
- Interviewee: Cheol Whan Lee
- Trial: 1) ZEST: Final Angiographic and IVUS Results From a Large-Scale Randomized Trial of Zotarolimus-Eluting, Sirolimus-Eluting and Paclitaxel-Eluting Stents; 2) CILOTAX: A Prospective, Randomized, Controlled Trial of a Stent Eluting Cilostazol and Paclitaxel
- Phone number:
1:15 PM
1:15 PM - 1:45 PM
- Interviewee: Flavio Ribichini
- Trial: CEREA-DES: A Prospective Randomized Trial of Corticosteroids in Patients Undergoing Stent Implantation
- Phone number:
1:45 PM
1:45 PM - 2:15 PM
- Interviewee: Josef Veselka
- Trial: STATINS PRE-PCI: A Prospective Randomized Trial of Statins Prior to Stent Implantation in Patients with Stable Angina
- Phone number:
2:15 PM
2:15 PM - 2:45 PM
- Interviewee: Patrick Ohlmann
- Trial: MISTRAL: A Prospective Randomized Trial of Ambulance-Initiated vs. Cath Lab-Initiated Intravenous Abciximab in Patients with STEMI
- Phone number:
2:45 PM
2:45 PM - 3:15 PM
- Interviewee: Junbo Ge
- Trial: NO REFLOW: A Prospective Randomized Trial of Intracoronary vs. Guide Catheter Infusion of Nitrates vs. Calcium Channel Blockers in Patients with No Reflow After Primary PCI in STEMI
- Phone number:
3:15 PM
3:15 PM - 3:45 PM
- Interviewee: Giulio Guagliumi
- Trial: OCTAMI: A Prospective Randomized Trial of Zotarolimus-Eluting and Bare-Metal Stents in STEMI Assessed by OCT
- Phone number:
3:45 PM
3:45 PM - 4:15 PM
- Interviewee: Josep Rodes-Cabau
- Trial: The Canadian Transcatheter Aortic Valve Implantation Program: Acute and Late Follow-up from a Multicenter Consecutive Series of Patients with Inoperable or High-Surgical Risk Aortic Stenosis
- Phone number:
4:15 PM
4:15 PM - 4:45 PM
- Interviewee: Dirk Walter
- Trial: PROVASA: A Prospective, Randomized, Placebo-Controlled Trial of Intra-Arterial Progenitor Cell Transplantation of Bone Marrow Mononuclear Cells in Patients with Peripheral Arterial Occlusive Disease
- Phone number:
Friday September 25, 2009
10:30 AM
10:30 AM - 11:00 AM
- Interviewee: Simon Redwood
- Trial: BCIS-1. A Prospective, Randomized Trial of Intraaortic Balloon Pump Counterpulsation in High-Risk Patients Undergoing PCI
- Phone number:
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Arnold Seto
- Trial: FAUST. A Prospective, Randomized Trial of Ultrasound-Guided vs. Standard Femoral Arterial Access
- Phone number:
12:30 PM
12:30 PM - 1:00 PM
- Interviewee: Rolf Michels
- Trial: DEBATER. A Prospective, Randomized Trial of Drug-Eluting vs. Bare Metal Stents With or Without Abciximab in STEMI
- Phone number:
1:00 PM
1:00 PM - 1:30 PM
- Interviewee: Gregg Stone
- Trial: 1) SPIRIT IV. A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents
2) PROSPECT. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque, 3) HORIZONS-AMI. 2-Year Follow-up From a Prospective, Randomized Trial of Heparin Plus Glycoprotein IIb/IIIa Inhibitors vs. Bivalirudin and Paclitaxel-Eluting vs. Bare Metal Stents in STEMI
- Phone number:
1:30 PM
1:30 PM - 2:00 PM
- Interviewee: Henry Krum
- Trial: SYMPLICITY I. 1-Year Results Following Sympathetic Renal Denervation in Refractory Hypertension
- Phone number: